309747-80-6 Usage
Molecular structure
Consists of a piperidine ring, a carboxylic acid functional group, a 1,1-dimethylethyl ester group, a phenylamino group, and an oxo-2-ethyl group.
Usage
Employed as an intermediate in the pharmaceutical industry for the synthesis of various drugs, including antihypertensive and antiarrhythmic medications.
Application in organic synthesis
Utilized in organic synthesis and chemical research.
Potential applications
Possesses diverse potential applications and is crucial in the development of new pharmaceuticals and other chemical products.
Check Digit Verification of cas no
The CAS Registry Mumber 309747-80-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,0,9,7,4 and 7 respectively; the second part has 2 digits, 8 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 309747-80:
(8*3)+(7*0)+(6*9)+(5*7)+(4*4)+(3*7)+(2*8)+(1*0)=166
166 % 10 = 6
So 309747-80-6 is a valid CAS Registry Number.
309747-80-6Relevant articles and documents
Heterocyclic analgesic compounds and methods of use thereof
-
, (2008/06/13)
One aspect of the present invention relates to novel heterocyclic compounds. A second aspect of the present invention relates to the use of the novel heterocyclic compounds as ligands for various cellular receptors, including opiate receptors, other G-protein-coupled receptors, and ion channels. An additional aspect of the present invention relates to the use of the novel heterocyclic compounds as analgesics.
Heterocyclic analgesic compounds and methods of use thereof
-
, (2008/06/13)
One aspect of the present invention relates to novel heterocyclic compounds. A second aspect of the present invention relates to the use of the novel heterocyclic compounds as ligands for various cellular receptors, including opiate receptors, other G-protein-coupled receptors, and ion channels. An additional aspect of the present invention relates to the use of the novel heterocyclic compounds as analgesics.
